140 related articles for article (PubMed ID: 19608901)
1. Molecular biology. Neutralizing toxic RNA.
Cooper TA
Science; 2009 Jul; 325(5938):272-3. PubMed ID: 19608901
[No Abstract] [Full Text] [Related]
2. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.
Wheeler TM; Sobczak K; Lueck JD; Osborne RJ; Lin X; Dirksen RT; Thornton CA
Science; 2009 Jul; 325(5938):336-9. PubMed ID: 19608921
[TBL] [Abstract][Full Text] [Related]
3. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
[TBL] [Abstract][Full Text] [Related]
4. Tackling the pathogenesis of RNA nuclear retention in myotonic dystrophy.
Mastroyiannopoulos NP; Shammas C; Phylactou LA
Biol Cell; 2010 Jul; 102(9):515-23. PubMed ID: 20690904
[TBL] [Abstract][Full Text] [Related]
5. Triplet-repeat transcripts: a role for DNA in disease.
Singer RH
Science; 1998 May; 280(5364):696-7. PubMed ID: 9599147
[No Abstract] [Full Text] [Related]
6. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
8. A muscleblind knockout model for myotonic dystrophy.
Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
[TBL] [Abstract][Full Text] [Related]
9. Myotonic syndromes.
Mankodi A; Thornton CA
Curr Opin Neurol; 2002 Oct; 15(5):545-52. PubMed ID: 12351998
[TBL] [Abstract][Full Text] [Related]
10. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
Klein AF; Gasnier E; Furling D
Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
[TBL] [Abstract][Full Text] [Related]
11. Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.
Christou M; Wengel J; Sokratous K; Kyriacou K; Nikolaou G; Phylactou LA; Mastroyiannopoulos NP
Nucleic Acid Ther; 2020 Apr; 30(2):80-93. PubMed ID: 31873063
[TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.
Mankodi A; Logigian E; Callahan L; McClain C; White R; Henderson D; Krym M; Thornton CA
Science; 2000 Sep; 289(5485):1769-73. PubMed ID: 10976074
[TBL] [Abstract][Full Text] [Related]
13. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.
Fardaei M; Larkin K; Brook JD; Hamshere MG
Nucleic Acids Res; 2001 Jul; 29(13):2766-71. PubMed ID: 11433021
[TBL] [Abstract][Full Text] [Related]
14. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
15. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.
Philips AV; Timchenko LT; Cooper TA
Science; 1998 May; 280(5364):737-41. PubMed ID: 9563950
[TBL] [Abstract][Full Text] [Related]
16. Nuclear RNA foci in the heart in myotonic dystrophy.
Mankodi A; Lin X; Blaxall BC; Swanson MS; Thornton CA
Circ Res; 2005 Nov; 97(11):1152-5. PubMed ID: 16254211
[TBL] [Abstract][Full Text] [Related]
17. Targeting nuclear RNA for in vivo correction of myotonic dystrophy.
Wheeler TM; Leger AJ; Pandey SK; MacLeod AR; Nakamori M; Cheng SH; Wentworth BM; Bennett CF; Thornton CA
Nature; 2012 Aug; 488(7409):111-5. PubMed ID: 22859208
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.
Yadava RS; Yu Q; Mandal M; Rigo F; Bennett CF; Mahadevan MS
Hum Mol Genet; 2020 Jun; 29(9):1440-1453. PubMed ID: 32242217
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophy: discussion of molecular basis.
Timchenko LT; Tapscott SJ; Cooper TA; Monckton DG
Adv Exp Med Biol; 2002; 516():27-45. PubMed ID: 12611434
[No Abstract] [Full Text] [Related]
20. Deconstructing myotonic dystrophy.
Tapscott SJ
Science; 2000 Sep; 289(5485):1701-2. PubMed ID: 11001736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
